Divis Laboratories Ltd to Approve Q3 and Nine Months Financial Results on February 11, 2026

Divis Laboratories Ltd has announced that its Board of Directors will meet on February 11, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The trading window for dealing in securities of the company will remain closed from January 01, 2026, to February 13, 2026, as per the earlier announcement.